M3258 [2285330-15-4]

MedChem Express

M3258 [2285330-15-4]

10

2285330-15-4

Research Use Only

98%

C17H20BNO5

329.16

M3258 is an orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (beta5i) inhibitor. M3258 exerts high biochemical (IC50=3.6 nM) and cellular (IC50=3.4 nM) potency against the LMP7 subunit. M3258 shows strong antitumor efficacy in multiple myeloma xenograft models. M3258 leads to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in multiple myeloma cells.

O=C(N[C@@H](CC1=COC2=C1C=CC=C2)B(O)O)[C@H]3[C@@H]4CC[C@@H](O4)C3

2°C to 8°C,-20°C,-80°C

12352200